Global Epilepsy Devices Market to Grow at 8.16% CAGR by 2028

Triton Market Research presents the Global Epilepsy Devices Market report sectioned by Device Type (Traditional Devices, Wearable Devices [Watches, Bracelets, Camera Devices, Mattress Devices, Anti-suffocation Pillows, Other Wearable Devices], Implantable Devices), Application (Vagus Nerve Stimulation, Deep Brain Stimulation [Movement Disorders, Epilepsy], Accelerometer, Responsive Neurostimulation), Detection and Prediction Device Type (Electroencephalogram, Intracranial EEG, Surface Electromyography, Electrocardiography, Video Detection Systems, Electrodermal Activity, Implanted Advisory Systems, Other Detection and Prediction Device Types), End-user (Hospitals & Clinics, Neurology Centers, Homecare Settings, Other End-users), and Regional Outlook (North America, Europe, Middle East and Africa, Latin America, Asia-Pacific).

The report further discusses the Market Summary, Industry Outlook, Impact of COVID-19, Key Insights, Porter’s Five Forces Analysis, Key Buying Impact Analysis, Market Attractiveness Index, Vendor Scorecard, Industry Components, Regulatory Framework, Key Market Strategies, Drivers, Challenges, Opportunities, Competitive Landscape, Research Methodology & Scope, Global Market Size, Forecasts & Analysis (2022-2028).

The report by Triton Market Research highlights that the global epilepsy devices market is estimated to witness growth at a CAGR of 8.16% over the forecast period 2022-2028.

Epilepsy devices refer to the equipment that diagnoses recurrent seizures involving instances of involuntary movement of the entire body or certain parts of the body.

The point-of-care systems help in the early identification, diagnosis, and treatment of epilepsy to achieve a positive outcome. If the beginning of a seizure (prognosis) can be identified or pre-treated using point-of-care (POC) systems, then epilepsy can be managed well while reducing fear. Furthermore, governments have overhauled the health systems to enhance healthcare services. They have also started developing legislative and regulatory frameworks, funding, recognizing existing care and resource gaps, and strengthening public-private partnerships. Thus, combating epilepsy through early detection and diagnosis can generate various opportunities for the epilepsy devices market.

However, the unawareness of epilepsy among the public and the inadequate number of neurology specialists in the healthcare system can negatively impact the development of the epilepsy devices market.

Globally, Asia-Pacific is anticipated to be the fastest-growing region in the epilepsy devices market. The region’s growth is due to the high prevalence of epilepsy and the growing geriatric population in the region. Additionally, the region is attracting key global players by offering training & research opportunities and favorable initiatives through the National Ministries of Health. These initiatives will identify needs and promote education, research, training, prevention, treatment, and care services. Thus, the aforementioned factors are anticipated to drive the region’s market growth throughout the forecasting period.

The prominent players in the epilepsy devices market include LivaNova Plc, Natus Medical Incorporated, Cadwell Industries Inc, Nihon Kohden Corporation, Compumedics Limited, Medtronic Plc, Boston Scientific Corporation, Empatica Inc, Koninklijke Philips NV, NeuroPace Inc, Drägerwerk AG & Co KGaA, Shenzhen Mindray Bio-Medical Electronics Co Ltd, and Neurosoft.

The companies in the market are focused on developing less expensive platforms to make the devices affordable. They are also attempting to develop new technologies that will give an edge to their products. For example, several manufacturers are integrating machine learning and artificial intelligence to improve product differentiation. Thus, the degree of competition in the epilepsy devices market is moderate.